Thus, AFP-positive was associated with higher pathological grades, more advanced TNM-7 stage, larger tumors, and inferior survival compared with AFP-negative, suggesting that oncologists should follow patients with HCC more closely and adjust treatment of those with AFP-positive as required. Here, AFP is linked to hepatocellular carcinoma.